Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MLTX compared with GHRS: revenue, margins and what each company keeps, and the suppliers and customers both name
MLTX
MoonLake Immunotherapeutics
Change
Mkt cap
Revenue
Revenue
GHRS
GH Research PLC
Change
Mkt cap
Revenue
Revenue
vs
Compare
MLTX
MoonLake Immunotherapeutics
vs
GHRS
GH Research PLC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
MLTX
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±23.0%
▼
−5.09%
×0.22
GHRS
No earnings history for GHRS.
= implied
MLTX realized, solid
GHRS realized, hatched
One scale, both sides: full bar = 24%
× = |realized| ÷ implied
Source: market data
MLTX
MoonLake Immunotherapeutics
Change
11.47
▼
−2.64%
· post 11.53
Mkt cap
$1.0B
GHRS
GH Research PLC
Change
20.79
▼
−0.34%
· post 20.79
Closed
Nov 2 '26
Mkt cap
$1.3B
vs
Compare
Closed
Nov 2 '26
MLTX
MoonLake Immunotherapeutics
vs
GHRS
GH Research PLC
11.47
▼
−2.64%
post 11.53
Price
20.79
▼
−0.34%
post 20.79
$1.0B
Mkt cap
$1.3B
Change
Change
MLTX
11.47
▼
−2.64%
vs
GHRS
20.79
▼
−0.34%
Closed
Nov 2 '26